Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults… CISION PRNewswireSeptember 9, 2026
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy Porustobart, a second-generation Fc-enhanced CTLA-4 antibody, is being advanced across two clinical… CISION PRNewswireSeptember 9, 2026
Press ReleaseReveillon Creations Builds Commercial Infrastructure for Malaysian Talent into China's Creator Economy Douyin licensing partnership with 3Z LIVE creates a cross-border route into China’s… CISION PRNewswireSeptember 9, 2026
OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes VANCOUVER, BC, Sept. 9, 2026 /PRNewswire/ — OceanaGold Corporation (TSX: OGC, NYSE:… CISION PRNewswireSeptember 9, 2026
SK keyfoundry Expands Collaboration with Elmos on 130nm Technology and Signs Long-Term Wafer Supply Agreement SEOUL, South Korea, Sept. 9, 2026 /PRNewswire/ — SK keyfoundry, an 8-inch… CISION PRNewswireSeptember 9, 2026
Press ReleaseYIKEDA™ Accelerates Global Expansion at ASIA FRUIT LOGISTICA 2026: Deepening Partnerships, Debuting Exclusive Traceability-Labeled Cherry Tomatoes HONG KONG and SHANGHAI, Sept. 9, 2026 /PRNewswire/ — From September 2… CISION PRNewswireSeptember 9, 2026
Robo.ai Announces Proposed Establishment of Alif Maritec, a Marine Security and Intelligent Maritime Infrastructure Company Wholly owned subsidiary of Alif Holding to focus on maritime protection, smart… CISION PRNewswireSeptember 9, 2026
Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026 Health In Tech recognized among the 100 highest-scoring U.S. public mid-market companies… CISION PRNewswireSeptember 9, 2026
